Komunikaty PR

UnlockLand Pioneers AI-Powered Platform to Support Canada's Most Ambitious Housing Plan Since WWII

2025-04-29  |  23:55:06
UNLOCKLAND logo

UNLOCKLAND logo

missing middle house

missing middle house

unlockland

unlockland

Vancouver-based AI platform cuts development planning from 12 weeks to minutes, helping deliver on Canada's ambitious 500,000 annual housing target

UnlockLand bridges the gap between zoning reforms and real housing by making development opportunities instantly visible and actionable.”
— LUCAS XIE, CPO, METON.AI

VANCOUVER, BRITISH COLUMBIA, CANADA, April 29, 2025 /EINPresswire.com/ -- With Canada’s housing sector poised for a historic transformation, Vancouver-based proptech innovator UnlockLand is uniquely positioned to serve as an AI catalyst for national-scale development under Prime Minister Mark Carney’s visionary housing strategy.

Carney’s newly elected Liberal government has boldly committed to doubling Canada’s annual housing output to 500,000 homes — the most ambitious construction target in the nation’s modern history. Their plan emphasizes catalyzing a new prefabrication industry and dramatically compressing development timelines across urban centers and rapidly growing suburban communities, setting the stage for an unprecedented housing boom.

“We built homes for returning veterans in the 1940s. Today, we must do the same for the next generation,” said Prime Minister Carney in his landmark policy address, signaling a transformative shift in federal housing priorities.

Developed by Vancouver-based startup Meton.ai, UnlockLand is a revolutionary AI-powered platform that employs advanced machine learning and geospatial analysis to automate site evaluation, zoning interpretation, and development planning — processes that traditionally require 8–12 weeks of professional consultation — condensing them into an actionable workflow that delivers comprehensive results in under 10 minutes.

“The housing crisis isn’t just about policy — it’s about execution at scale,” said Stephen Wong, CEO and co-founder of Meton.ai. “UnlockLand bridges the critical gap between zoning reforms and actual construction by making development opportunities instantly visible and executable for stakeholders across the housing ecosystem.”

As municipalities nationwide prepare to implement sweeping zoning reforms supported by the new federal Housing Accelerator Fund, UnlockLand is rapidly expanding its pilot programs across major Canadian provinces. The platform empowers city planners, nonprofit developers, and private builders to instantly identify buildable lots, uncover hidden as-of-right multiplex opportunities, and generate standardized, prefab-optimized building scenarios ready for fast-tracked approvals.

A particularly innovative feature of UnlockLand is its seamless integration with Canada’s emerging prefabrication and modular housing sector. By matching developable sites to mass timber and factory-built construction systems, UnlockLand directly supports the federal Build Canada Homes (BCH) initiative, which seeks to establish Canada as a global leader in sustainable, factory-built housing solutions.

“Traditional development models cannot scale quickly enough to meet Canada’s housing targets,” noted Jessica Chen, Chief Technology Officer of Meton.ai. “Our technology streamlines the most complex stages of feasibility and design, enabling housing projects to move from concept to construction far more efficiently.”

UnlockLand has already demonstrated remarkable results through pilot projects across British Columbia. In collaboration with municipal partners, the platform identified thousands of previously overlooked infill sites capable of supporting over 20,000 new housing units, while compressing pre-development analysis timelines from months to weeks.

Industry experts are increasingly recognizing UnlockLand’s potential to democratize access to development expertise, particularly for smaller builders and community housing organizations traditionally excluded from the housing market due to complexity and cost barriers.

“UnlockLand doesn’t just analyze land — it unlocks opportunity,” said Wong. “By removing information barriers and streamlining decision-making, we’re making it possible for more Canadians to participate in solving the housing crisis.”

Following its successful pilots, UnlockLand is scaling its presence to Ontario, Quebec, and other key regions, while deepening its collaboration with housing authorities, municipalities, and nonprofit organizations. The platform’s mission-driven approach — combining data-driven decision-making with a focus on affordability, density, and sustainability — aligns directly with Canada’s bold new housing agenda.

About UnlockLand
UnlockLand, created by Meton.ai, harnesses real-time data and generative AI to identify untapped land value, streamline development feasibility, and accelerate housing creation across Canada. Founded in 2024 by a multidisciplinary team of experts from Harvard, Microsoft, and Tsinghua University, UnlockLand is redefining how communities approach residential development through technological innovation. The company’s mission is to democratize access to development expertise while optimizing land use for greater density, affordability, and sustainability.

lucas xie
meton ai inc
+1 778-239-4166
email us here

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Newseria nie ponosi odpowiedzialności za treści oraz inne materiały (np. infografiki, zdjęcia) przekazywane w „Biurze Prasowym”, których autorami są zarejestrowani użytkownicy tacy jak agencje PR, firmy czy instytucje państwowe.
Ostatnio dodane
komunikaty PR z wybranej przez Ciebie kategorii
EIN Newswire BRAK ZDJĘCIA
2025-06-17 | 04:55:04

DXRacer, 전설적인 저격수 kennyS와 손잡고 e스포츠 역사의 새로운 장을 열다

KennyS X DXRACER CollaborationMartian ProKennyS Legend SniperDXRACER— 장인정신으로 클래식을 기리고, 혁신을 통해 미래를 포용하다SEOUL, SOUTH KOREA, June 17, 2025 /EINPresswire.com/ -- [전설적인 동맹: 최고의
EIN Newswire BRAK ZDJĘCIA
2025-06-17 | 03:55:06

NEXCOM EBC 370 Powers Autonomous Robotics for Industrial Applications

Highly Efficient, Edge AI Computing Delivered in a Compact New CPUThe EBC 370/EBC 370X is an AI-powered, PC-based controller designed to adapt to the most demanding conditions. Research labs use it as the main control unit for advanced robotics
EIN Newswire BRAK ZDJĘCIA
2025-06-17 | 03:55:06

The End Brain Cancer Initiative Partners with Curis to Pre-qualify for PCNSL TakeAim Lymphoma Clinical Trial

The End Brain Cancer Initiative Partners with Curis to Promote Awareness and Pre-qualify for PCNSL TakeAim Lymphoma Clinical Trial REDMOND, WA, UNITED STATES, June 16, 2025 /EINPresswire.com/ -- FOR IMMEDIATE RELEASE Contact: Dellann Elliott Mydland, 425-785-8489, Dellann@EndBrainCancer.org The End Brain Cancer Initiative Partners with Curis to Promote Awareness and Pre-qualify for PCNSL TakeAim Lymphoma Clinical Trial The End Brain Cancer Initiative (EBCI) has partnered with Curis to promote awareness and pre-qualify patients for the company’s TakeAim Lymphoma Clinical Trial (CA-4948-101) clinical trial, an open-label, dose escalation and expansion trial of Emavusertib in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/​R PCNSL) (NCT03328078). “We are proud to partner with the End Brain Cancer Initiative to help raise awareness for primary CNS lymphoma (PCNSL), a rare and challenging form of cancer non-Hodgkin lymphoma. Together, we aim to highlight the unmet medical needs of this patient community, provide relevant resources to patients and their care providers, along with increasing awareness of clinical trials,” shared the Chief Medical Officer of Curis Inc, Ahmed Hamdy, MD. “Curis is committed to developing emavusertib for the treatment of PCNSL and broader non-Hodgkin lymphoma indications.” Patients who would like to learn more about this clinical trial and see if they qualify can visit https://endbraincancer.org/curis-therapeutics/ or contact the End Brain Cancer Initiative’s Clinical Research Coordinator and Patient Navigator, Shreya Prakash, at Shreya@EndBrainCancer.org or 425-436-8688. About Curis Curis, located in Lexington, Massachusetts, is a biotechnology company focused on the development of Emavusertib, an orally available, small molecule IRAK4 inhibitor. Emavusertib is currently being evaluated in the TakeAim Lymphoma Phase 1/2 study (CA-4948-101) in patients with relapsed/refractory primary central nervous system lymphoma (PCNSL) in combination with the BTK inhibitor ibrutinib, as a monotherapy in the TakeAim Leukemia Phase 1/2 study (CA-4948-102) in patients with relapsed/refractory acute myeloid leukemia (AML) and relapsed/refractory high risk myelodysplastic syndrome (hrMDS), and as a frontline combination therapy with venetoclax and azacitidine in patents with AML (CA-4948-104). Emavusertib has received Orphan Drug Designation from the U.S. Food and Drug Administration for the treatment of PCNSL, AML and MDS and from the European Commission for the treatment of PCNSL. Curis, through its 2015 collaboration with Aurigene, has the exclusive license to Emavusertib (CA-4948). Curis licensed its rights to Erivedge® to Genentech, a member of the Roche Group, under which they are commercializing Erivedge® for the treatment of advanced basal cell carcinoma. For more information, visit Curis's website at https://www.curis.com/. About the End Brain Cancer Initiative To support/donate to the End Brain Cancer Initiative’s increased access and health delivery for patients, mission, services and programs, please visit EndBrainCancer.org The End Brain Cancer Initiative (EBCI) is a 501(c)3 non-profit patient advocacy organization focused on disease education, awareness, outreach, increasing patient access and improving Standard of Care. The End Brain Cancer Initiative, formerly known as the Chris Elliott Fund (CEF), is dedicated to ensuring that all patients diagnosed with brain cancer, a brain tumor, or metastatic disease to the brain have equal access to advanced diagnostics, treatments, specialists, and clinical trial participation. We believe that IMMEDIATE ACCESS to these options provides this patient community with the best HOPE for survival and sustained quality of life. We partner with industry, patients, researchers, advocacy groups, medical teams, hospital networks and others to educate patients and their caregivers so they can have empowered conversations with their medical teams. Learn more about the End Brain Cancer Initiative or how to sponsor this annual campaign at EndBrainCancer.org. Dellann Elliott Mydland, End Brain Cancer Initiative, 425-785-8489, Dellann@EndBrainCancer.org

Kalendarium

Więcej ważnych informacji

Jedynka Newserii

Jedynka Newserii

Kongres Profesjonalistów Public Relations

Ochrona środowiska

Z powodu braku przejrzystego prawa branża recyklingu odkłada inwestycje. Firmy apelują o szybkie wdrożenie przepisów

Branża recyklingu stoi przed wyzwaniami związanymi z wdrożeniem systemu kaucyjnego, systemu rozszerzonej odpowiedzialności producenta i rozporządzenia PPWR. Brakuje jednak odpowiednich przepisów dostosowujących polskie prawo i realia do unijnych regulacji. W efekcie utrzymującej się niepewności prawnej między 2018 a 2023 rokiem co trzeci zakład recyklingu zamknął działalność. Wiele firm odkłada inwestycje, czekając na uregulowanie rynku. Podobna niepewność dotyczy też producentów opakowań. 

Transport

Testowanie pojazdów zautomatyzowanych wkrótce będzie możliwe. To odpowiedź na postulaty przedsiębiorców

Kończą się prace nad przepisami, które mają usprawnić prace badawcze nad pojazdami zautomatyzowanymi. Ma to być odpowiedź na postulaty przedsiębiorców, którzy wskazywali na potrzebę pilnej zmiany przepisów w zakresie testowania pojazdów autonomicznych. Obecne regulacje nie sprzyjają postępowi technologicznemu i rozwoju autonomiczności pojazdów, o czym świadczy bardzo niewielka liczba wydanych uprawnień do ich prowadzenia.

Firma

Przedsiębiorcom coraz bardziej doskwiera niestabilność i skomplikowanie przepisów podatkowych. Problemem są też niejasne ich interpretacje

Polscy przedsiębiorcy często negatywnie oceniają jakość przepisów podatkowych – wynika z raportu „Przedsiębiorcy pod lupą fiskusa 2025” przygotowanego przez firmę doradztwa podatkowego MDDP we współpracy z Konfederacją Lewiatan. Ich niepokój budzą niejednolite interpretacje przepisów i niepewność prawa podatkowego, które cały czas jest modyfikowane. Wśród kluczowych zmian w obszarze podatków, które będą dotyczyć praktycznie wszystkich przedsiębiorców, są m.in. wprowadzenie Krajowego Systemu e-Faktur czy zmiany w podatku od nieruchomości.

Partner serwisu

Instytut Monitorowania Mediów

Szkolenia

Akademia Newserii

Akademia Newserii to projekt, w ramach którego najlepsi polscy dziennikarze biznesowi, giełdowi oraz lifestylowi, a  także szkoleniowcy z wieloletnim doświadczeniem dzielą się swoją wiedzą nt. pracy z mediami.